SANTA CLARA,
Calif., June 25, 2024 /PRNewswire/ -- Zeto, Inc.,
an award-winning medical technology firm, is proud to announce the
winners of its 2024 Clinical Trial Sponsorship program. This
initiative, announced at the 2023 Society for Neuroscience
Convention in Washington D.C.,
invited research teams to submit proposals for clinical trials
using the Zeto EEG device platform. The program aims to support
advanced clinical research and to bring innovative applications
closer to real-world implementation.
An expert jury panel, composed of professionals
from the fields of neurology and neuroscience research, carefully
reviewed all submissions and selected the winners based on several
factors, including alignment with Zeto's mission to enhance patient
care through innovative EEG applications.
"The winners of the 2024 Clinical Trial
Sponsorship program are conducting groundbreaking research aimed at
improving patient care. These projects align perfectly with Zeto's
mission, and we are proud to support them. We look forward to
continuing this sponsorship program annually," said Florian
Strelzyk, Chief Sales Officer at Zeto.
The winners of the 2024 Clinical Trial
Sponsorship program are:
- Efficacy of Portable EEG Technology in Pre-hospital Triage
of Large Vessel Occlusion Strokes by Liqi Shu, MD and a multidisciplinary team from
Brown University and Rhode
Island Hospital, USA
This clinical trial will evaluate the Zeto EEG system's ability
to enhance pre-hospital triage of large vessel occlusion (LVO)
strokes, aiming to significantly improve diagnostic speed and
accuracy. By integrating Zeto's advanced, portable EEG technology
into EMS protocols, the study seeks to ensure rapid and appropriate
routing of stroke patients to specialized care facilities, thereby
optimizing treatment times and patient outcomes.
- Gaze-independent visual brain computer interface for use by
patients with limited to no eye control by Marc M. Van Hulle, Ph.D., and Arne Van Den Kerchove, Ph.D. from KU Leuven,
Belgium
Brain computer interfaces (BCIs) have been
serving paralyzed individuals by decoding their brain activity
directly. A popular paradigm requires the patient to gaze at
displayed targets but this is challenging for patients with limited
to no eye control. Prof. Hulle's team has developed a
gaze-independent paradigm and EEG decoder that copes with this
issue, which will be tested on patients using the Zeto EEG
headset.
- The Far-North Remote Online Zeto Electroencephalography
(F.R.O.Z.E.) Trial by Marcus C. Ng, MD from
University of Manitoba, Canada
The FROZE Trial will use Zeto EEG in an emergency
room in the far north of the Canadian Arctic for use by everyday
clinicians backed by remote interpretation by board-certified
epileptologists. This trial will determine how effectively the Zeto
platform could improve patient care in even the remotest regions of
the Earth.
"We are happy to support the winners of the
Clinical Trial Sponsorship program and to see the advantages of
Zeto's dry EEG headset in action. Its ease of use, comfort, and
ability to bring EEG out of the lab and into the medical research
environment provide significant benefits to researchers in projects
such as these," said A. Mark Mento,
Director of Enterprise Sales at Zeto.
Zeto will provide each clinical trial with its
FDA cleared products, including up to two headsets per trial along
with electrode supplies for up to 100 patients, accompanied by
on-site training and ongoing product support. Trials are set to
start before the end of 2024 with an anticipated duration ranging
between 6 to 12 months.
About Zeto, Inc.
Zeto, Inc., an award-winning medical technology
firm, is at the forefront of advancing EEG brain monitoring and
diagnostics for healthcare.
Zeto's revolutionary FDA-cleared EEG platform brings the
traditional EEG procedure to the 21st century by offering a
zero-prep, wireless, easy-to-wear, portable headsets with active,
dry electrodes that can be positioned as per the 10-20 system.
The company plans to leverage its platform technology to improve
access and quality to medical EEG testing and to enable and improve
adjacent biomedical research and clinical trials.
To learn more about Zeto's products, please
visit https://zeto-inc.com or email us at
research@zetoinc.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zeto-announces-winners-of-clinical-trial-sponsorship-program-302181053.html
SOURCE Zeto, Inc.